Diabetes medicine sales in Belgium are forecasted to experience a gradual increase from 2024 to 2028, rising from 3.8% of total sales in 2024 to 4.2% in 2028. This consistent year-on-year increase represents a stable growth pattern, averaging around 2.5% annually. Compared to 2023, when sales stood at 3.7% of total sales, the upward trend is evident, showing a robust market for diabetes medications. The compound annual growth rate (CAGR) for the 2024-2028 period is anticipated to be approximately 2.6%, indicating steady market expansion over five years.
Future trends to watch for include advancements in diabetes treatment technologies, the introduction of innovative drugs, increased healthcare spending, and awareness programs. The aging population and rising incidence of diabetes are also expected to continue driving demand. Monitoring regulatory changes and price fluctuations will be key in anticipating market dynamics.
